Stock 600538 BEIHAI GOFAR CHUANSHAN BIOLOGICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Beihai Gofar Chuanshan Biological Co., Ltd.

Equities

600538

CNE000001DD2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-07 pm EDT 		5-day change 1st Jan Change
4.12 CNY +0.24% Intraday chart for Beihai Gofar Chuanshan Biological Co., Ltd. -0.72% -11.21%
Apr. 29 Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 22 Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.

Number of employees: 463

Sales per Business

CNY in Million2022Weight2023Weight Delta
Medical Circulation
54.6 %
191 41.6 % 201 54.6 % +5.31%
DNA Testing Equipment, Consumables and Testing Services
31.7 %
182 39.6 % 117 31.7 % -35.74%
Pharmaceutical Manufacturing
12.0 %
62 13.5 % 44 12.0 % -28.55%
Others
1.8 %
25 5.4 % 7 1.8 % -73.07%
Inter-segment Elimination
-0.6 %
-3 -0.6 % -2 -0.6 % -14.91%
Other Business
0.6 %
2 0.5 % 2 0.6 % -14.29%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
460 100.0 % 369 100.0 % -19.69%

Managers

Managers TitleAgeSince
Li Bin Pan CEO
 Chief Executive Officer 60 09-09-24
Zhi Bo Yin DFI
 Director of Finance/CFO 57 10-05-17
Yong Li BRD
 Director/Board Member 59 00-12-31
Li Ping Li IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Li Bin Pan CEO
 Chief Executive Officer 60 09-09-24
Yong Li BRD
 Director/Board Member 59 00-12-31
Yan Chen BRD
 Director/Board Member 41 11-04-06
Yan Lin Ceng BRD
 Director/Board Member 45 -
Lu Yu BRD
 Director/Board Member 60 14-03-09
Qiu Jun Lu CHM
 Chairman 60 17-05-14
Zhen Hua Huang BRD
 Director/Board Member 52 17-05-14
Pei Cheng Wu BRD
 Director/Board Member 49 21-05-16
Ze Yang Xu BRD
 Director/Board Member 45 20-05-13
Xiao Fang Song BRD
 Director/Board Member 51 20-05-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 524,198,348 358,319,583 ( 68.36 %) 0 68.36 %

Shareholders

NameEquities%Valuation
Gfund Management Co., Ltd.
0.7846 %
3,643,600 0.7846 % 2 M ¥
Western Leadbank Fund Management Co., Ltd
0.2631 %
1,222,000 0.2631 % 687 852 ¥
Everbright PGIM Fund Management Co. Ltd.
0.1461 %
678,500 0.1461 % 381 921 ¥
Zhong Ou Asset Management Co., Ltd
0.0721 %
335,000 0.0721 % 188 568 ¥
Hongde Fund Management Co., Ltd.
0.0613 %
284,500 0.0613 % 160 142 ¥
Lion Fund Management Co., Ltd.
0.0572 %
265,800 0.0572 % 149 616 ¥
JPMorgan Asset Management (China) Co Ltd.
0.0406 %
188,700 0.0406 % 106 217 ¥
Beixin Ruifeng Fund Management Co., Ltd.
0.0183 %
84,800 0.0183 % 47 733 ¥
Tebon Fund Management Co. Ltd.
0.0145 %
67,200 0.0145 % 37 826 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.002175 %
10,100 0.002175 % 5 685 ¥

Company contact information

Beihai Gofar Chuanshan Biological Co., Ltd.

3 Beibuwan Middle Road

536000, Beihai

+

http://www.gofar.com.cn
address Beihai Gofar Chuanshan Biological Co., Ltd.(600538)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
BEIHAI GOFAR CHUANSHAN BIOLOGICAL CO., LTD. Stock Beihai Gofar Chuanshan Biological Co., Ltd.
-11.21% 297M
MCKESSON CORPORATION Stock McKesson Corporation
+27.41% 76.47B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+13.87% 8.65B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-3.18% 8.09B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-36.08% 6.38B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+24.91% 5.61B
GALENICA AG Stock Galenica AG
+2.61% 4.15B
EBOS GROUP LIMITED Stock EBOS Group Limited
-7.61% 3.89B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
-11.12% 3.26B
MEDIPAL HOLDINGS CORPORATION Stock MediPal Holdings Corporation
+9.93% 3.2B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 600538 Stock
  4. Company Beihai Gofar Chuanshan Biological Co., Ltd.